Skip to content

Clinical study of efficacy of Bruhatiphal,Haridra,Daruharidra kwath application in vaginal cavity in Upapluta Yonivyapada(Vaginal candidiasis in pregnancy)

A Randomized, Controlled, Clinical study of application of Bruhatiphal,Daruharidra,Haridra kwath for vaginal painting in Upapluta Yonivyapada with special reference to vaginal candidiasis in pregnancy - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/085841
Enrollment
30
Registered
2025-04-28
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N00-N99- Diseases of the genitourinary system

Interventions

None listed

Sponsors

Dr.Varsha Shantilal Shelake
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Clinically diagnosed cases of Upapluta Yonivyapada with vaginal candidiasis in pregnancy having symptoms of White thick curdy vaginal discharge Vaginal itching Pregnat patient of 20 weeks to 36 weeks

Exclusion criteria

Exclusion criteria: First trimester pregnant patient Premature rupture of membrane Premature labour Placenta previa Cervical malignancy Other systemic disorder like Diabetes, Tuberculosis,HIV, Sexually Transmitted diseases

Design outcomes

Primary

MeasureTime frame
Efficacy of Bruhatiphal, Daruharidra, Haridra kwath vaginal painting in Upapluta Yonivyapada and assessment of releived symptoms like wthite thick curdy vaginal discharge, vaginal itchingTimepoint: 5 days

Secondary

MeasureTime frame
NilTimepoint: Nil

Countries

India

Contacts

Public ContactDrManjusha Rupchand Meshram

Government Ayurved College, Nanded

varshashelake74@gmail.com7774920984

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026